Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post Triumph Gold Announces the Acquisition of the Coyote Knoll Silver-Gold Mineral Property – Located in Central Utah next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case You may also like Settlement of Tranche 1 Share Placement June 26, 2025 Should You Invest in Silver Bullion? June 6, 2025 SPUT’s US$200 Million Uranium Buying Plan Spurs Market... June 18, 2025 Ford Government Pushes Bill 5 Through Legislature, Sparking... June 7, 2025 Munda Gold Mine Mining Progresses: First Blast June 19, 2025 Mobile Gaming Stocks: 10 Biggest Companies in 2025 June 17, 2025 Resolution Minerals LtdTo Develop U.S. Government Engagement Strategy... June 18, 2025 Mali Court Seizes Control of Barrick Gold Mine... June 20, 2025 Justin Huhn: Uranium Game On — Supply “Mirage,”... June 6, 2025 Critical Metals Secures US$120 Million Loan LOI for... June 20, 2025